Cargando…

Multikinase Inhibitor Treatment Patterns for Advanced Thyroid Cancer in Japan: An Administrative Claims Database Study

BACKGROUND: The multikinase inhibitors (MKIs) sorafenib, lenvatinib, and vandetanib are approved for advanced thyroid cancer (TC) in Japan. How sequential treatment with MKIs is conducted in Japanese clinical practice is unknown. METHODS: This retrospective observational cohort study used a Japanese...

Descripción completa

Detalles Bibliográficos
Autores principales:	Masaki, Chie, Sugino, Kiminori, Tanizawa, Yoshinori, Nakamura, Kenichi, Okada, Yui, Cai, Zhihong, Okamoto, Takahiro
Formato:	Online Artículo Texto
Lenguaje:	English
Publicado:	Springer International Publishing 2022
Materias:	Original Research Article
Acceso en línea:	https://www.ncbi.nlm.nih.gov/pmc/articles/PMC9943803/ https://www.ncbi.nlm.nih.gov/pubmed/36527599 http://dx.doi.org/10.1007/s40801-022-00346-y

Ejemplares similares

Treatment Pattern for Advanced Gastric Cancer in Japan and Factors Associated with Sequential Treatment: A Retrospective Administrative Claims Database Study
por: Komatsu, Yoshito, et al.
Publicado: (2021)

Multikinase Inhibitor Treatment in Thyroid Cancer
por: Ancker, Ole Vincent, et al.
Publicado: (2019)

Treatment sequences of patients with advanced colorectal cancer and use of second-line FOLFIRI with antiangiogenic drugs in Japan: A retrospective observational study using an administrative database
por: Shinozaki, Eiji, et al.
Publicado: (2021)

Asthma Controller Medications for Children in Japan: Analysis of an Administrative Claims Database
por: Hamada, Shota, et al.
Publicado: (2015)

Monitoring and evaluating the quality of cancer care in Japan using administrative claims data
por: Iwamoto, Momoko, et al.
Publicado: (2015)

Multikinase inhibitors use in differentiated thyroid carcinoma
por: Jasim, Sina, et al.
Publicado: (2014)

Emerging role of multikinase inhibitors for refractory thyroid cancer
por: Perez, Cesar A, et al.
Publicado: (2012)

Timing of multikinase inhibitor initiation in differentiated thyroid cancer
por: Brose, Marcia S, et al.
Publicado: (2017)

A Review of Research Studies Using Data from the Administrative Claims Databases in Japan
por: Fujinaga, Jun, et al.
Publicado: (2022)

Prevalence of Noncommunicable Diseases in Japan Using a Newly Developed Administrative Claims Database Covering Young, Middle-aged, and Elderly People
por: Okada, Akira, et al.
Publicado: (2022)

Risk stratification in differentiated thyroid cancer with RAI-avid lung metastases
por: Ohkuwa, Keiko, et al.
Publicado: (2021)

Chemosensitivity of Anaplastic Thyroid Cancer Based on a Histoculture Drug Response Assay
por: Uruno, Takashi, et al.
Publicado: (2015)

Multikinase inhibitors in the treatment of thyroid cancer: specific role of lenvatinib
por: Stjepanovic, Neda, et al.
Publicado: (2014)

Use of multikinase inhibitors/lenvatinib in singular thyroid cancer scenarios
por: Zafón, Carles, et al.
Publicado: (2022)

How are new drugs disseminated in Japan? Analysis using the National Database of Health Insurance Claims of Japan
por: Watanabe, Tomone, et al.
Publicado: (2022)

Serum Intact Parathyroid Hormone Level After Total Thyroidectomy or Total Thyroidectomy Plus Lymph Node Dissection for Thyroid Nodules: Report From 296 Surgical Cases
por: Yano, Yukiko, et al.
Publicado: (2012)

Neoadjuvant Multikinase Inhibitor in Patients With Locally Advanced Unresectable Thyroid Carcinoma
por: Nava, Carla Fernanda, et al.
Publicado: (2019)

Outcomes for Recurrent Mantle Cell Lymphoma Post-Ibrutinib Therapy: A Retrospective Cohort Study from a Japanese Administrative Database
por: Rai, Shinya, et al.
Publicado: (2022)

Association of Albumin-Bilirubin Grade and Sequential Treatment with Standard Systemic Therapies for Advanced Hepatocellular Carcinoma: A Retrospective Cohort Study Using a Japanese Administrative Database
por: Hiraoka, Atsushi, et al.
Publicado: (2021)

Prevalence, treatments and medical cost of multiple sclerosis in Japan based on analysis of a health insurance claims database
por: Ogino, Mieko, et al.
Publicado: (2017)

Hypnotic prescription trends and patterns for the treatment of insomnia in Japan: analysis of a nationwide Japanese claims database
por: Okuda, Shoki, et al.
Publicado: (2023)

Real‐world burden and treatment of chronic rhinosinusitis in Japan: A retrospective claims database analysis
por: Yoshikawa, Mamoru, et al.
Publicado: (2023)

Rapid disease progression after discontinuation of lenvatinib in thyroid cancer
por: Yamazaki, Haruhiko, et al.
Publicado: (2020)

Predictors of Response and Survival to Multikinase Inhibitors in Radioiodine Resistant Differentiated Thyroid Cancer
por: Feola, Tiziana, et al.
Publicado: (2021)

Potential use of multikinase inhibitors in immunosuppressed patients with malignancies including thyroid cancer
por: Basté Rotllan, Neus
Publicado: (2022)

Patient characteristics, treatment patterns, and outcomes of hormone receptor-positive, human epidermal growth factor receptor 2-negative advanced breast cancer patients prescribed cyclin-dependent kinase 4 and 6 inhibitors: large-scale data analysis using a Japanese claims database
por: Kawai, Masaaki, et al.
Publicado: (2022)

Response to neoadjuvant paclitaxel predicts survival in anaplastic thyroid carcinoma
por: Yamazaki, Haruhiko, et al.
Publicado: (2022)

THU682 Long-term Outcomes Of Prophylactic Lateral Neck Dissection In Papillary Thyroid Carcinoma
por: Matsui, Ai, et al.
Publicado: (2023)

Changes in the Penetration Rate of Biosimilar Infliximab Within Japan Using a Japanese Claims Database
por: Matsumoto, Tsugumi, et al.
Publicado: (2021)

Recent transition of medical cost and relapse rate of multiple sclerosis in Japan based on analysis of a health insurance claims database
por: Kawachi, Izumi, et al.
Publicado: (2019)

Prescription pattern of anti-Parkinson's disease drugs in Japan based on a nationwide medical claims database
por: Suzuki, Masahiko, et al.
Publicado: (2020)

Real-world evidence of trifluridine/tipiracil plus bevacizumab in metastatic colorectal cancer using an administrative claims database in Japan
por: Kagawa, Y., et al.
Publicado: (2023)

Rare complications of multikinase inhibitor treatment
por: Pitoia, Fabián, et al.
Publicado: (2018)

Stereotactic radiotherapy using the CyberKnife is effective for local control of bone metastases from differentiated thyroid cancer
por: Ishigaki, Takayuki, et al.
Publicado: (2019)

Treatment pattern and clinical outcomes in multiple myeloma patients in Japan using the Medical Data Vision claims database
por: Handa, Hiroshi, et al.
Publicado: (2023)

Impact of lenvatinib on renal function: long-term analysis of differentiated thyroid cancer patients
por: Masaki, Chie, et al.
Publicado: (2021)

Incidence rates for hospitalized infections, herpes zoster, and malignancies in patients with ulcerative colitis in Japan: an administrative health claims database analysis
por: Matsuoka, Katsuyoshi, et al.
Publicado: (2023)

MON-552 Prognostic Impact of the Turin Criteria in Poorly Differentiated Thyroid Carcinoma
por: Akaishi, Junko, et al.
Publicado: (2019)

Use of multikinase inhibitors/lenvatinib concomitant with radioiodine for the treatment of radioiodine refractory differentiated thyroid cancer
por: Herranz, Urbano Anido
Publicado: (2022)

Recent trends in anti-vascular endothelial growth factor intravitreal injections: a large claims database study in Japan
por: Hashimoto, Yohei, et al.
Publicado: (2022)

Cannot write session to /tmp/vufind_sessions/sess_s058ahne0fb1kda0ig0204dn33